The	O
29-kDa	B-protein
proteins	I-protein
phosphorylated	O
in	O
thrombin-activated	B-cell_line
human	I-cell_line
platelets	I-cell_line
are	O
forms	O
of	O
the	O
estrogen	B-protein
receptor-related	I-protein
27-kDa	I-protein
heat	I-protein
shock	I-protein
protein	I-protein
.	O

Thrombin	B-protein
plays	O
a	O
critical	O
role	O
in	O
platelet	O
activation	O
,	O
hemostasis	O
,	O
and	O
thrombosis	O
.	O

Cellular	O
activation	O
by	O
thrombin	O
leads	O
to	O
the	O
phosphorylation	O
of	O
multiple	B-protein
proteins	I-protein
,	O
most	O
of	O
which	O
are	O
unidentified	O
.	O

We	O
have	O
characterized	O
several	O
29-kDa	B-protein
proteins	I-protein
that	O
are	O
rapidly	O
phosphorylated	O
following	O
exposure	O
of	O
intact	B-cell_type
human	I-cell_type
platelets	I-cell_type
to	O
thrombin	B-protein
.	O

A	O
murine	B-protein
monoclonal	I-protein
antibody	I-protein
raised	O
to	O
an	O
unidentified	B-protein
estrogen	I-protein
receptor-related	I-protein
29-kDa	I-protein
protein	I-protein
selectively	O
recognized	O
these	O
proteins	O
as	O
well	O
as	O
a	O
more	O
basic	O
,	O
unphosphorylated	B-protein
27-kDa	I-protein
protein	I-protein
.	O

Cellular	O
activation	O
by	O
thrombin	B-protein
led	O
to	O
a	O
marked	O
shift	O
in	O
the	O
proportion	O
of	O
protein	O
from	O
the	O
27-kDa	B-protein
unphosphorylated	I-protein
form	I-protein
to	O
the	O
29-kDa	B-protein
phosphoprotein	I-protein
species	I-protein
.	O

Using	O
this	O
antibody	O
,	O
we	O
isolated	O
and	O
sequenced	O
a	O
human	O
cDNA	B-DNA
clone	I-DNA
encoding	O
a	O
protein	O
that	O
was	O
identical	O
to	O
the	O
mammalian	B-protein
27-kDa	I-protein
heat	I-protein
shock	I-protein
protein	I-protein
(	O
HSP27	B-protein
)	O
,	O
a	O
protein	O
of	O
uncertain	O
function	O
that	O
is	O
known	O
to	O
be	O
phosphorylated	O
to	O
several	O
forms	O
and	O
to	O
be	O
transcriptionally	O
induced	O
by	O
estrogen	O
.	O

The	O
29-kDa	B-protein
proteins	I-protein
were	O
confirmed	O
to	O
be	O
phosphorylated	O
forms	O
of	O
HSP27	B-protein
by	O
immunoprecipitation	O
studies	O
.	O

Thus	O
,	O
the	O
``	O
estrogen	O
receptor-related	O
protein	O
''	O
is	O
HSP27	B-protein
,	O
and	O
the	O
three	O
major	O
29-kDa	B-protein
proteins	I-protein
phosphorylated	O
in	O
thrombin-activated	B-cell_type
platelets	I-cell_type
are	O
forms	O
of	O
HSP27	B-protein
.	O

These	O
data	O
suggest	O
a	O
role	O
for	O
HSP27	B-protein
in	O
the	O
signal	O
transduction	O
events	O
of	O
platelet	B-cell_type
activation	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

88	NULL
,	NULL
pp	NULL
.	NULL

11212-11216	NULL
,	NULL
December	NULL
1991	NULL
Cell	NULL
Biology	NULL
The	NULL
29-kDa	NULL
proteins	NULL
phosphorylated	NULL
in	NULL
thrombin-activated	NULL
human	NULL
platelets	NULL
are	NULL
forms	NULL
of	NULL
the	NULL
estrogen	NULL
receptor-related	NULL
27-kDa	NULL
heat	NULL
shock	NULL
protein	NULL
(	NULL
signal	NULL
transduction	NULL
/thrombosis	NULL
/	NULL
platelet	NULL
activation	NULL
)	NULL
MICHAEL	NULL
E.	NULL
MENDELSOHN*	NULL
,	NULL
YAN	NULL
ZHU	NULL
,	NULL
AND	NULL
SARAK	NULL
O'NEILL	NULL
Cardiovascular	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
and	NULL
Center	NULL
for	NULL
Research	NULL
in	NULL
Cardiovascular	NULL
Biology	NULL
,	NULL
Brockton/WRVA	NULL
Medical	NULL
Center	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
Communicated	NULL
by	NULL
Eugene	NULL
Braunwald	NULL
,	NULL
September	NULL
23	NULL
,	NULL
1991	NULL
(	NULL
received	NULL
for	NULL
review	NULL
June	NULL
3	NULL
,	NULL
1991	NULL
)	NULL
ABSTRACT	NULL
-	NULL
Thrombin	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
platelet	NULL
activation	NULL
,	NULL
hemostasis	NULL
,	NULL
and	NULL
thrombosis	NULL
.	NULL

Cellular	NULL
activation	NULL
by	NULL
thrombin	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
multiple	NULL
proteins	NULL
,	NULL
most	NULL
of	NULL
which	NULL
are	NULL
unidentified	NULL
.	NULL

We	NULL
have	NULL
characterized	NULL
several	NULL
29-kDa	NULL
proteins	NULL
that	NULL
are	NULL
rapidly	NULL
phosphorylated	NULL
following	NULL
exposure	NULL
of	NULL
intact	NULL
human	NULL
platelets	NULL
to	NULL
thrombin	NULL
.	NULL

A	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
to	NULL
an	NULL
unidentified	NULL
estrogen	NULL
receptor-related	NULL
29-kDa	NULL
protein	NULL
selectively	NULL
recognized	NULL
these	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
a	NULL
more	NULL
basic	NULL
,	NULL
unphosphorylated	NULL
27-kDa	NULL
protein	NULL
.	NULL

Cellular	NULL
activation	NULL
by	NULL
thrombin	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
shift	NULL
in	NULL
the	NULL
proportion	NULL
of	NULL
protein	NULL
from	NULL
the	NULL
27-kDa	NULL
unphosphorylated	NULL
form	NULL
to	NULL
the	NULL
29-kDa	NULL
phosphoprotein	NULL
species	NULL
.	NULL

Using	NULL
this	NULL
antibody	NULL
,	NULL
we	NULL
isolated	NULL
and	NULL
sequenced	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
encoding	NULL
a	NULL
protein	NULL
that	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
mammalian	NULL
27-kDa	NULL
heat	NULL
shock	NULL
protein	NULL
(	NULL
HSP27	NULL
)	NULL
,	NULL
aproteinofuneertainfnnctionthatisknowntobe	NULL
phosphorylated	NULL
to	NULL
several	NULL
forms	NULL
and	NULL
to	NULL
be	NULL
transcriptionally	NULL
induced	NULL
by	NULL
estrogen	NULL
.	NULL

The	NULL
29-kDa	NULL
proteins	NULL
were	NULL
confirmed	NULL
to	NULL
be	NULL
phosphorylated	NULL
forms	NULL
of	NULL
HSP27	NULL
by	NULL
immunoprecipitation	NULL
stud-ies	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
“	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
``	NULL
is	NULL
HSP27	NULL
,	NULL
and	NULL
the	NULL
three	NULL
major	NULL
29-kDa	NULL
proteins	NULL
phosphorylated	NULL
in	NULL
thrombin-activated	NULL
platelets	NULL
are	NULL
forms	NULL
of	NULL
HSP27	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
a	NULL
role	NULL
for	NULL
HSP27	NULL
in	NULL
the	NULL
signal	NULL
transduction	NULL
events	NULL
of	NULL
platelet	NULL
activation	NULL
.	NULL

e	NULL
Thrombin	NULL
is	NULL
the	NULL
most	NULL
potent	NULL
physiologic	NULL
agonist	NULL
of	NULL
platelet	NULL
activation	NULL
(	NULL
1-3	NULL
)	NULL
and	NULL
initiates	NULL
platelet	NULL
secretion	NULL
and	NULL
aggregation	NULL
in	NULL
the	NULL
developing	NULL
thrombus	NULL
by	NULL
activating	NULL
several	NULL
important	NULL
Signal	NULL
transduction	NULL
pathways	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

4	NULL
)	NULL
.	NULL

One	NULL
thrombin	NULL
receptor	NULL
has	NULL
recently	NULL
been	NULL
cloned	NULL
and	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
novel	NULL
proteolytic	NULL
mechanism	NULL
of	NULL
activation	NULL
(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
subsequent	NULL
steps	NULL
in	NULL
platelet	NULL
activation	NULL
by	NULL
thrombin	NULL
and	NULL
the	NULL
contributions	NULL
of	NULL
known	NULL
signal	NULL
transduction	NULL
pathways	NULL
to	NULL
specific	NULL
platelet	NULL
activation	NULL
events	NULL
are	NULL
less	NULL
well	NULL
understood	NULL
.	NULL

Protein	NULL
kinase-mediated	NULL
events	NULL
are	NULL
ubiquitous	NULL
in	NULL
cellular	NULL
activation	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
refs	NULL
.	NULL

6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
kinases	NULL
involved	NULL
in	NULL
cellular	NULL
Signaling	NULL
are	NULL
only	NULL
partially	NULL
characterized	NULL
,	NULL
however	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
specific	NULL
cellular	NULL
substrates	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
physiologic	NULL
ago-nists	NULL
.	NULL

Platelet	NULL
activation	NULL
by	NULL
thrombin	NULL
leads	NULL
to	NULL
marked	NULL
increases	NULL
in	NULL
the	NULL
level	NULL
of	NULL
[	NULL
*P	NULL
]	NULL
phosphate	NULL
incorporation	NULL
by	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Studies	NULL
to	NULL
date	NULL
have	NULL
emphasized	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
20-kDa	NULL
protein	NULL
identified	NULL
subsequently	NULL
as	NULL
the	NULL
light	NULL
chain	NULL
of	NULL
myosin	NULL
and	NULL
the	NULL
40-	NULL
to	NULL
47-kDa	NULL
protein	NULL
kinase	NULL
C	NULL
substrate	NULL
(	NULL
s	NULL
)	NULL
(	NULL
2	NULL
,	NULL
4	NULL
)	NULL
.	NULL

Three	NULL
unidentified	NULL
29-kDa	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
phosphorylated	NULL
in	NULL
platelets	NULL
activated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
physiologic	NULL
agonists	NULL
(	NULL
11	NULL
)	NULL
and	NULL
to	NULL
be	NULL
similar	NULL
or	NULL
identical	NULL
to	NULL
proteins	NULL
in	NULL
fibroblasts	NULL
(	NULL
11	NULL
)	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

11212	NULL
The	NULL
heat	NULL
shock	NULL
proteins	NULL
consist	NULL
of	NULL
a	NULL
number	NULL
of	NULL
highly	NULL
conserved	NULL
proteins	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
protective	NULL
role	NULL
in	NULL
cells	NULL
subjected	NULL
to	NULL
high	NULL
temperature	NULL
or	NULL
other	NULL
stresses	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Evidence	NULL
suggests	NULL
that	NULL
these	NULL
proteins	NULL
are	NULL
synthesized	NULL
for	NULL
reasons	NULL
in	NULL
addition	NULL
to	NULL
thermotolerance	NULL
and	NULL
are	NULL
present	NULL
(	NULL
and	NULL
often	NULL
essential	NULL
)	NULL
for	NULL
normal	NULL
cell	NULL
functions	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
high	NULL
molecular	NULL
weight	NULL
heat	NULL
shock	NULL
proteins	NULL
HSP90	NULL
,	NULL
HSP70	NULL
,	NULL
and	NULL
HSP60	NULL
(	NULL
GroEL	NULL
)	NULL
,	NULL
have	NULL
been	NULL
studied	NULL
in	NULL
greatest	NULL
detail	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
as	NULL
molecular	NULL
*'chaperones	NULL
``	NULL
'	NULL
in	NULL
some	NULL
interactions	NULL
,	NULL
such	NULL
as	NULL
that	NULL
between	NULL
HSP90	NULL
and	NULL
steroid	NULL
receptor	NULL
complexes	NULL
(	NULL
15	NULL
)	NULL
or	NULL
between	NULL
HSPI0	NULL
and	NULL
protooncogene	NULL
products	NULL
with	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
(	NULL
13	NULL
)	NULL
.	NULL

However	NULL
,	NULL
even	NULL
with	NULL
these	NULL
two	NULL
examples	NULL
the	NULL
precise	NULL
function	NULL
of	NULL
the	NULL
HSP90	NULL
,	NULL
the	NULL
nature	NULL
and	NULL
role	NULL
of	NULL
other	NULL
associated	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
role	NULL
of	NULL
HSP90	NULL
phosphorylation	NULL
remain	NULL
unclear	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

The	NULL
low	NULL
molecular	NULL
weight	NULL
heat	NULL
shock	NULL
proteins	NULL
are	NULL
the	NULL
least	NULL
well	NULL
understood	NULL
members	NULL
of	NULL
the	NULL
heat	NULL
shock	NULL
protein	NULL
family	NULL
(	NULL
13	NULL
)	NULL
.	NULL

At	NULL
least	NULL
three	NULL
potential	NULL
levels	NULL
of	NULL
regulation	NULL
exist	NULL
for	NULL
the	NULL
low	NULL
molecular	NULL
weight	NULL
heat	NULL
shock	NULL
proteins	NULL
:	NULL
their	NULL
synthesis	NULL
is	NULL
temperature-induced	NULL
;	NULL
they	NULL
are	NULL
induced	NULL
as	NULL
well	NULL
at	NULL
specific	NULL
developmental	NULL
stages	NULL
at	NULL
normal	NULL
temperature	NULL
;	NULL
and	NULL
they	NULL
are	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
characterize	NULL
three	NULL
major	NULL
29-kDa	NULL
proteins	NULL
phosphorylated	NULL
following	NULL
platelet	NULL
activation	NULL
by	NULL
throm-bin	NULL
,	NULL
identify	NULL
these	NULL
phosphoproteins	NULL
as	NULL
forms	NULL
of	NULL
HSP27	NULL
,	NULL
and	NULL
establish	NULL
that	NULL
the	NULL
previously	NULL
unidentified	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
(	NULL
16	NULL
)	NULL
is	NULL
HSP27	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

Sepharose	NULL
2B	NULL
,	NULL
Tween	NULL
20	NULL
,	NULL
Kodak	NULL
X-Omat	NULL
film	NULL
,	NULL
and	NULL
3,3'-diaminobenzidine	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

[	NULL
P	NULL
]	NULL
JOrthophosphate	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

Nitro-cellulose	NULL
(	NULL
0.45	NULL
um	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
.	NULL

Poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
(	NULL
PVDF	NULL
)	NULL
Immobilon	NULL
membranes	NULL
were	NULL
frpm	NULL
Millipore	NULL
.	NULL

Goat	NULL
anti-mouse	NULL
IgG	NULL
horseradish	NULL
peroxidase	NULL
conjugate	NULL
was	NULL
purchased	NULL
from	NULL
Amersham	NULL
.	NULL

Protein	NULL
A-Sepharose	NULL
was	NULL
from	NULL
Pharmacia	NULL
.	NULL

DS	NULL
antibody	NULL
,	NULL
a	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
against	NULL
an	NULL
unidentified	NULL
27-	NULL
to	NULL
29-kDa	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
(	NULL
16	NULL
)	NULL
,	NULL
has	NULL
recently	NULL
become	NULL
available	NULL
from	NULL
Amersham	NULL
International	NULL
(	NULL
U.K.	NULL
)	NULL
.	NULL

DNA	NULL
sequencing	NULL
gel	NULL
solution	NULL
,	NULL
Hydrolink	NULL
,	NULL
was	NULL
purchased	NULL
from	NULL
AT	NULL
Biochem	NULL
(	NULL
Malvern	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Restriction	NULL
endonu-cleases	NULL
,	NULL
DNA-modifying	NULL
enzymes	NULL
,	NULL
and	NULL
T3	NULL
and	NULL
T7	NULL
promoter	NULL
primers	NULL
were	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Electrophoresis	NULL
supplies	NULL
were	NULL
from	NULL
Bio-Rad	NULL
.	NULL

Human	NULL
a-thrombin	NULL
was	NULL
from	NULL
Abbreviations	NULL
:	NULL
IEF	NULL
,	NULL
isoelectric	NULL
focusing	NULL
;	NULL
PVDF	NULL
,	NULL
poly	NULL
(	NULL
vinylidene	NULL
difluoride	NULL
)	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
75	NULL
Francis	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Cell	NULL
Biology	NULL
:	NULL
Mendelsohn	NULL
et	NULL
al	NULL
.	NULL

Enzyme	NULL
Research	NULL
Laboratories	NULL
(	NULL
South	NULL
Bend	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

All	NULL
other	NULL
reagents	NULL
were	NULL
the	NULL
highest	NULL
quality	NULL
available	NULL
commercially	NULL
.	NULL

Platelet	NULL
Isolation	NULL
and	NULL
Separation	NULL
.	NULL

Platelets	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
volunteers	NULL
and	NULL
gel-filtered	NULL
platelets	NULL
were	NULL
prepared	NULL
(	NULL
17	NULL
)	NULL
.	NULL

All	NULL
preparations	NULL
and	NULL
subsequent	NULL
experiments	NULL
were	NULL
performed	NULL
at	NULL
22°C	NULL
.	NULL

Platelets	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
130	NULL
mM	NULL
NaCl/10	NULL
mM	NULL
trisodium	NULL
cit-rate/10	NULL
mM	NULL
Tris	NULL
base/9	NULL
mM	NULL
NaHCO	NULL
;	NULL
/6	NULL
mM	NULL
dextrose/0.9	NULL
mM	NULL
MgCl	NULL
;	NULL
/0.81	NULL
mM	NULL
KH	NULL
;	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
pH	NULL
7.3	NULL
)	NULL
.	NULL

After	NULL
filtration	NULL
on	NULL
Sepharose	NULL
2B	NULL
,	NULL
platelet	NULL
aliquots	NULL
were	NULL
subjected	NULL
to	NULL
various	NULL
experimental	NULL
conditions	NULL
and	NULL
pelleted	NULL
at	NULL
appropriate	NULL
time	NULL
points	NULL
.	NULL

For	NULL
phosphorylation	NULL
experiments	NULL
,	NULL
platelets	NULL
were	NULL
resuspended	NULL
for	NULL
1	NULL
hr	NULL
in	NULL
2	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
containing	NULL
1.0	NULL
mCi	NULL
(	NULL
37	NULL
MBq	NULL
)	NULL
of	NULL
P	NULL
;	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
gel-filtered	NULL
and	NULL
entered	NULL
into	NULL
expenments	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
term	NULL
phosphorylatlon	NULL
as	NULL
used	NULL
in	NULL
this	NULL
report	NULL
is	NULL
synonymous	NULL
with	NULL
the	NULL
net	NULL
increase	NULL
in	NULL
protein-associated	NULL
*P	NULL
as	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

Two-Dimensional	NULL
Gel	NULL
Electrophoresis	NULL
.	NULL

Platelet	NULL
pellets	NULL
from	NULL
0.8-1.9	NULL
x	NULL
10°	NULL
platelets	NULL
(	NULL
see	NULL
figure	NULL
legends	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
and	NULL
subjected	NULL
to	NULL
two-dimensional	NULL
isoelectric	NULL
focusing	NULL
(	NULL
IEF	NULL
)	NULL
-SDS/PAGE	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Upon	NULL
completion	NULL
,	NULL
gels	NULL
were	NULL
either	NULL
stained	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
and	NULL
dried	NULL
for	NULL
autoradiography	NULL
or	NULL
removed	NULL
directly	NULL
for	NULL
immunoblotting	NULL
.	NULL

Silver	NULL
staining	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Morrissey	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Molecular	NULL
weight	NULL
standards	NULL
were	NULL
used	NULL
to	NULL
provnde	NULL
reference	NULL
values	NULL
and	NULL
to	NULL
localize	NULL
the	NULL
29-kDa	NULL
proteins	NULL
in	NULL
all	NULL
gels	NULL
.	NULL

Immunobiotting	NULL
.	NULL

For	NULL
immunoblotting	NULL
studies	NULL
,	NULL
two-dimensional	NULL
gels	NULL
from	NULL
*	NULL
``	NULL
P-labeled	NULL
platelets	NULL
were	NULL
electroblotted	NULL
to	NULL
PVDF	NULL
membranes	NULL
for	NULL
60-90	NULL
min	NULL
at	NULL
500	NULL
mA	NULL
,	NULL
rinsed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
and	NULL
blocked	NULL
overnight	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
subsequently	NULL
incubated	NULL
with	NULL
DS	NULL
antibody	NULL
at	NULL
a	NULL
1:400	NULL
dilution	NULL
in	NULL
PBS	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Blots	NULL
were	NULL
rinsed	NULL
extensively	NULL
and	NULL
developed	NULL
using	NULL
a	NULL
horseradish	NULL
peroxidase	NULL
system	NULL
followed	NULL
by	NULL
diaminobenzidine	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Immunoblots	NULL
from	NULL
immunoprecipitation	NULL
experiments	NULL
were	NULL
prepared	NULL
from	NULL
SDS/12.5	NULL
%	NULL
polyacrylamide	NULL
minigels	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
or	NULL
probed	NULL
with	NULL
a	NULL
1:1000	NULL
dilution	NULL
of	NULL
a	NULL
murine	NULL
monoclonal	NULL
anti-HSP27	NULL
antibody	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
William	NULL
McGuire	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
,	NULL
San	NULL
Antonio	NULL
)	NULL
,	NULL
and	NULL
developed	NULL
as	NULL
above	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
2-mercaptoethanol	NULL
was	NULL
omitted	NULL
from	NULL
the	NULL
SDS/	NULL
PAGE	NULL
sample	NULL
buffer	NULL
to	NULL
prevent	NULL
reduction	NULL
of	NULL
the	NULL
DS	NULL
antibody	NULL
itself	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

Experiments	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
using	NULL
a	NULL
radioimmunoprecipitation	NULL
assay	NULL
(	NULL
RIPA	NULL
)	NULL
lysis	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4/50	NULL
mM	NULL
NaCl/50	NULL
mM	NULL
NaF/5	NULL
mM	NULL
EDTA/20	NULL
mM	NULL
sodium	NULL
pyrophos-phate/1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride/1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
/1	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
Triton	NULL
X-100	NULL
.	NULL

Immunoprecipitates	NULL
containing	NULL
1-2	NULL
x	NULL
10°	NULL
platelets	NULL
were	NULL
precleared	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
DS	NULL
antibody	NULL
(	NULL
10-20	NULL
ul	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
incubation	NULL
at	NULL
4°C	NULL
with	NULL
rocking	NULL
,	NULL
immune	NULL
complexes	NULL
were	NULL
isolated	NULL
by	NULL
addition	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
pelleted	NULL
,	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
at	NULL
4°C	NULL
with	NULL
RIPA	NULL
buffer	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
solubilized	NULL
by	NULL
addition	NULL
of	NULL
SDS/PAGE	NULL
sample	NULL
buffer	NULL
and	NULL
immunoblots	NULL
were	NULL
prepared	NULL
as	NULL
above	NULL
.	NULL

Autoradiography	NULL
.	NULL

Dried	NULL
gels	NULL
or	NULL
**P-labeled	NULL
electroblots	NULL
were	NULL
exposed	NULL
to	NULL
X-Omat	NULL
AR	NULL
film	NULL
at	NULL
-70°C	NULL
in	NULL
cassettes	NULL
equipped	NULL
with	NULL
DuPont	NULL
Cronex	NULL
intensifying	NULL
screens	NULL
for	NULL
various	NULL
times	NULL
.	NULL

Densitometry	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
300A	NULL
computing	NULL
densitometer	NULL
(	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
the	NULL
integrated	NULL
volume	NULL
mode	NULL
.	NULL

Values	NULL
were	NULL
expressed	NULL
in	NULL
arbitrary	NULL
densitometric	NULL
units	NULL
(	NULL
ADU	NULL
)	NULL
.	NULL

Immunoscreening	NULL
of	NULL
cDNA	NULL
Libraries	NULL
.	NULL

Random-	NULL
and	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-primed	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cell	NULL
cDNA	NULL
libraries	NULL
were	NULL
constructed	NULL
in	NULL
Agt11	NULL
as	NULL
reported	NULL
(	NULL
24	NULL
)	NULL
and	NULL
were	NULL
gifts	NULL
of	NULL
S.	NULL
Orkin	NULL
(	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
)	NULL
.	NULL

The	NULL
platelet	NULL
cDNA	NULL
library	NULL
in	NULL
Agt11	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
K.	NULL
Clemetson	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Immunoscreening	NULL
of	NULL
recombinant	NULL
phage	NULL
with	NULL
monoclonal	NULL
antibody	NULL
DS	NULL
was	NULL
essentially	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Positive	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
-	NULL
11213	NULL
clones	NULL
were	NULL
plaque-purified	NULL
by	NULL
three	NULL
additional	NULL
rescreening	NULL
steps	NULL
to	NULL
obtain	NULL
a	NULL
single	NULL
plaque	NULL
.	NULL

Isolation	NULL
and	NULL
Sequencing	NULL
of	NULL
Recombinant	NULL
Phage	NULL
DNA	NULL
.	NULL

Phage	NULL
DNA	NULL
was	NULL
purified	NULL
from	NULL
plate	NULL
lysates	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Purified	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
insert	NULL
fragments	NULL
were	NULL
isolated	NULL
by	NULL
electrophoresis	NULL
in	NULL
low-melting-temperature	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
inserts	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
EcoRI-digested	NULL
plasmid	NULL
vector	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
insert	NULL
was	NULL
sequenced	NULL
as	NULL
a	NULL
double-stranded	NULL
form	NULL
by	NULL
the	NULL
chain-termination	NULL
method	NULL
(	NULL
28	NULL
)	NULL
with	NULL
the	NULL
enzyme	NULL
Sequenase	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Eugene	NULL
Software	NULL
program	NULL
developed	NULL
at	NULL
Baylor	NULL
College	NULL
and	NULL
available	NULL
through	NULL
the	NULL
Molecular	NULL
Biology	NULL
Computer	NULL
Research	NULL
Resource	NULL
(	NULL
Dana-Farber	NULL
Cancer	NULL
Insti-tute	NULL
,	NULL
Boston	NULL
)	NULL
.	NULL

RESULTS	NULL
Two-Dimensional	NULL
IEF-SDS/PAGE	NULL
Analysis	NULL
of	NULL
Protein	NULL
Phosphorylation	NULL
in	NULL
Human	NULL
Platelets	NULL
.	NULL

An	NULL
autoradiograph	NULL
of	NULL
a	NULL
two-dimensional	NULL
gel	NULL
from	NULL
*P-labeled	NULL
platelets	NULL
followmg	NULL
thrombin	NULL
stimulation	NULL
is	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Increases	NULL
in	NULL
phosphorylation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
were	NULL
consistently	NULL
observed	NULL
in	NULL
thrombin-stimulated	NULL
platelets	NULL
,	NULL
including	NULL
three	NULL
major	NULL
29-kDa	NULL
proteins	NULL
(	NULL
292-c	NULL
)	NULL
.	NULL

Isoelectric	NULL
points	NULL
for	NULL
these	NULL
proteins	NULL
(	NULL
average	NULL
of	NULL
10	NULL
gels	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
29a	NULL
,	NULL
6.8	NULL
;	NULL
29b	NULL
,	NULL
6.5	NULL
;	NULL
29c	NULL
,	NULL
5.7	NULL
.	NULL

These	NULL
three	NULL
phosphoproteins	NULL
form	NULL
the	NULL
subject	NULL
of	NULL
this	NULL
report	NULL
.	NULL

Proteins	NULL
29a-c	NULL
were	NULL
not	NULL
visible	NULL
following	NULL
staining	NULL
of	NULL
two-dimensional	NULL
gels	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
but	NULL
could	NULL
be	NULL
clearly	NULL
seen	NULL
after	NULL
silver	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
amounts	NULL
of	NULL
the	NULL
three	NULL
proteins	NULL
,	NULL
determined	NULL
by	NULL
silver	NULL
staining	NULL
,	NULL
were	NULL
29b	NULL
>	NULL
>	NULL
292	NULL
>	NULL
29c	NULL
.	NULL

The	NULL
corresponding	NULL
pattern	NULL
of	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
demonstrated	NULL
29¢	NULL
to	NULL
be	NULL
most	NULL
prominently	NULL
phosphorylated	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
stoi-chiometry	NULL
of	NULL
phosphorylation	NULL
of	NULL
29¢	NULL
is	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
292	NULL
or	NULL
29b	NULL
.	NULL

A	NULL
small	NULL
degree	NULL
of	NULL
phosphorylation	NULL
of	NULL
several	NULL
cellular	NULL
proteins	NULL
is	NULL
known	NULL
to	NULL
occur	NULL
in	NULL
resting	NULL
platelets	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
.	NULL

Identification	NULL
of	NULL
29-kDa	NULL
phosphoproteins	NULL
from	NULL
P-labeled	NULL
human	NULL
platelets	NULL
.	NULL

Lysate	NULL
from	NULL
10°	NULL
thrombin-stimulated	NULL
(	NULL
1	NULL
unit/ml	NULL
,	NULL
2	NULL
min	NULL
)	NULL
,	NULL
P-labeled	NULL
platelets	NULL
was	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
two-dimensional	NULL
IEF-SDS/12.5	NULL
%	NULL
PAGE	NULL
on	NULL
12.5	NULL
%	NULL
gels	NULL
.	NULL

Shown	NULL
is	NULL
a	NULL
representative	NULL
autoradiograph	NULL
from	NULL
thrombin-stimulated	NULL
platelets	NULL
prepared	NULL
in	NULL
this	NULL
manner	NULL
and	NULL
electroblotted	NULL
to	NULL
PVDF	NULL
(	NULL
39-hr	NULL
expo-sure	NULL
)	NULL
.	NULL

Reference	NULL
pH	NULL
values	NULL
for	NULL
the	NULL
IEF	NULL
(	NULL
first	NULL
)	NULL
dimension	NULL
and	NULL
molecular	NULL
size	NULL
standards	NULL
(	NULL
kDa	NULL
)	NULL
for	NULL
the	NULL
SDS/PAGE	NULL
(	NULL
second	NULL
)	NULL
dimension	NULL
are	NULL
marked	NULL
and	NULL
identify	NULL
three	NULL
principal	NULL
,	NULL
acidic	NULL
29-kDa	NULL
proteins	NULL
.	NULL

These	NULL
phosphoprotems	NULL
,	NULL
labeled	NULL
29a-c	NULL
,	NULL
are	NULL
highlighted	NULL
in	NULL
the	NULL
boxed	NULL
area	NULL
,	NULL
which	NULL
is	NULL
detailed	NULL
in	NULL
Figs	NULL
.	NULL

2-4	NULL
.	NULL

11214	NULL
-	NULL
Cell	NULL
Biology	NULL
:	NULL
Mendelsohn	NULL
et	NULL
al	NULL
.	NULL

t	NULL
t	NULL
”	NULL
,	NULL
tte	NULL
Who	NULL
``	NULL
FiG	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Silver	NULL
stain	NULL
identification	NULL
of	NULL
the	NULL
29-kDa	NULL
phosphoproteins	NULL
in	NULL
human	NULL
platelets	NULL
.	NULL

A	NULL
two-dimensional	NULL
gel	NULL
of	NULL
10°	NULL
thrombin-stimulated	NULL
(	NULL
1	NULL
unit/ml	NULL
,	NULL
2	NULL
min	NULL
)	NULL
,	NULL
P-labeled	NULL
platelets	NULL
was	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
silver	NULL
staining	NULL
(	NULL
A	NULL
)	NULL
followed	NULL
by	NULL
autoradiography	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
orientation	NULL
of	NULL
the	NULL
acidic	NULL
(	NULL
+	NULL
)	NULL
and	NULL
basic	NULL
(	NULL
-	NULL
)	NULL
ends	NULL
of	NULL
the	NULL
first-dimension	NULL
gel	NULL
and	NULL
the	NULL
position	NULL
of	NULL
the	NULL
31-kDa	NULL
molecular	NULL
size	NULL
marker	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
phosphorylated	NULL
proteins	NULL
29a-c	NULL
in	NULL
B	NULL
migrated	NULL
exactly	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
were	NULL
directly	NULL
superimposable	NULL
on	NULL
the	NULL
silver-stained	NULL
proteins	NULL
bearing	NULL
the	NULL
same	NULL
labels	NULL
in	NULL
A.	NULL
Phosphorylation	NULL
of	NULL
proteins	NULL
292-c	NULL
was	NULL
minimal	NULL
in	NULL
resting	NULL
platelets	NULL
,	NULL
with	NULL
prominent	NULL
increases	NULL
in	NULL
phosphorylation	NULL
within	NULL
60	NULL
sec	NULL
of	NULL
stimulation	NULL
by	NULL
thrombin	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
revealed	NULL
that	NULL
*P	NULL
incorporation	NULL
into	NULL
proteins	NULL
292a-c	NULL
increased	NULL
1.6-	NULL
,	NULL
1.5-	NULL
,	NULL
and	NULL
3.3-fold	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
30	NULL
sec	NULL
and	NULL
2.1-	NULL
,	NULL
4.6-	NULL
,	NULL
and	NULL
7.1-fold	NULL
,	NULL
respectively	NULL
,	NULL
at	NULL
60	NULL
sec	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
phosphorylation	NULL
at	NULL
60	NULL
sec	NULL
was	NULL
essentially	NULL
the	NULL
same	NULL
as	NULL
that	NULL
at	NULL
2	NULL
min	NULL
(	NULL
cf	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
)	NULL
or	NULL
4	NULL
min	NULL
of	NULL
thrombin	NULL
exposure	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

We	NULL
consistently	NULL
observed	NULL
the	NULL
small	NULL
phosphoprotein	NULL
adjacent	NULL
to	NULL
29¢	NULL
as	NULL
well	NULL
,	NULL
which	NULL
may	NULL
be	NULL
a	NULL
fourth	NULL
protein	NULL
form	NULL
or	NULL
an	NULL
artifact	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

lmmunoblotoIW-Labeledl	NULL
’	NULL
lauletl	NULL
’	NULL
roteinswithbs	NULL
a	NULL
Monoclonal	NULL
Antibody	NULL
Against	NULL
an	NULL
Unidentified	NULL
Estrogen	NULL
Receptor-Related	NULL
29-kDa	NULL
Phosphoprotein	NULL
.	NULL

Extensive	NULL
attempts	NULL
to	NULL
obtain	NULL
protein	NULL
sequence	NULL
for	NULL
29a-c	NULL
from	NULL
two-dimensional	NULL
gels	NULL
transferred	NULL
to	NULL
PVDF	NULL
were	NULL
unsuccessful	NULL
,	NULL
in	NULL
part	NULL
because	NULL
the	NULL
amino	NULL
termini	NULL
of	NULL
proteins	NULL
292a-c	NULL
were	NULL
blocked	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

An	NULL
immunologic	NULL
approach	NULL
was	NULL
simultaneously	NULL
pursued	NULL
to	NULL
identify	NULL
292-c	NULL
,	NULL
in	NULL
which	NULL
candidate	NULL
antibodies	NULL
for	NULL
the	NULL
platelet	NULL
proteins	NULL
were	NULL
used	NULL
to	NULL
screen	NULL
two-dimensional	NULL
immunoblots	NULL
.	NULL

DS	NULL
,	NULL
a	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
by	NULL
Coffer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
during	NULL
attempts	NULL
to	NULL
obtain	NULL
antibody	NULL
to	NULL
the	NULL
purified	NULL
estrogen	NULL
receptor	NULL
,	NULL
had	NULL
been	NULL
shown	NULL
to	NULL
recognize	NULL
29-kDa	NULL
phosphoprotein	NULL
(	NULL
s	NULL
)	NULL
with	NULL
characteristics	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
29-kDa	NULL
platelet	NULL
proteins	NULL
(	NULL
16	NULL
,	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Preliminary	NULL
experiments	NULL
confirmed	NULL
the	NULL
ability	NULL
of	NULL
antibody	NULL
DS	NULL
ONDS	NULL
P	NULL
@	NULL
‘	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
29a-c.	NULL
P-labeled	NULL
platelets	NULL
were	NULL
analyzed	NULL
by	NULL
two-dimensional	NULL
IEF-SDS/	NULL
PAGE	NULL
without	NULL
stimulation	NULL
(	NULL
control	NULL
)	NULL
or	NULL
following	NULL
activation	NULL
by	NULL
human	NULL
thrombin	NULL
(	NULL
1	NULL
unit/ml	NULL
)	NULL
for	NULL
30	NULL
or	NULL
60	NULL
sec	NULL
.	NULL

Care	NULL
was	NULL
taken	NULL
to	NULL
apply	NULL
identical	NULL
quantities	NULL
of	NULL
platelet	NULL
lysate	NULL
(	NULL
1.1	NULL
x	NULL
10°	NULL
platelets	NULL
per	NULL
gel	NULL
)	NULL
to	NULL
each	NULL
gel	NULL
.	NULL

Autoradiographs	NULL
(	NULL
9-hr	NULL
exposure	NULL
)	NULL
of	NULL
portions	NULL
of	NULL
the	NULL
gels	NULL
containing	NULL
the	NULL
29-kDa	NULL
proteins	NULL
from	NULL
these	NULL
three	NULL
time	NULL
points	NULL
are	NULL
displayed	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
to	NULL
recognize	NULL
29-kDa	NULL
proteins	NULL
in	NULL
samples	NULL
from	NULL
human	NULL
platelets	NULL
.	NULL

Because	NULL
of	NULL
recent	NULL
studies	NULL
of	NULL
the	NULL
thrombin-induced	NULL
phosphorylation	NULL
of	NULL
similar	NULL
28-	NULL
to	NULL
30-kDa	NULL
proteins	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
first-passage	NULL
*P-labeled	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Gimbrone	NULL
,	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
)	NULL
and	NULL
found	NULL
that	NULL
29-kDa	NULL
phosphoproteins	NULL
were	NULL
similarly	NULL
detectable	NULL
with	NULL
the	NULL
DS	NULL
antibody	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Two-dimensional	NULL
immunoblots	NULL
from	NULL
*P-labeled	NULL
platelets	NULL
demonstrated	NULL
precise	NULL
recognition	NULL
of	NULL
the	NULL
phosphorylated	NULL
proteins	NULL
29a-c	NULL
by	NULL
antibody	NULL
DS	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
Upper	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
more	NULL
basic	NULL
,	NULL
unphosphorylated	NULL
27-kDa	NULL
protein	NULL
(	NULL
arrowhead	NULL
)	NULL
was	NULL
clearly	NULL
recognized	NULL
by	NULL
DS	NULL
on	NULL
the	NULL
immunoblots	NULL
.	NULL

Strikingly	NULL
,	NULL
the	NULL
predominant	NULL
species	NULL
in	NULL
control	NULL
(	NULL
unstimulated	NULL
)	NULL
platelets	NULL
was	NULL
the	NULL
unphosphorylated	NULL
27-kDa	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
Upper	NULL
)	NULL
,	NULL
while	NULL
stimulation	NULL
of	NULL
the	NULL
platelets	NULL
with	NULL
thrombin	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
27-kDa	NULL
protein	NULL
detected	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
each	NULL
of	NULL
the	NULL
three	NULL
proteins	NULL
29a-c	NULL
on	NULL
the	NULL
immunoblots	NULL
.	NULL

The	NULL
phosphorylation	NULL
pattern	NULL
generated	NULL
from	NULL
these	NULL
immunoblots	NULL
demonstrated	NULL
a	NULL
parallel	NULL
increase	NULL
in	NULL
the	NULL
phosphorylated	NULL
species	NULL
29a-c	NULL
following	NULL
thrombin	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
Lower	NULL
;	NULL
cf	NULL
.	NULL

Figs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

Densitometry	NULL
revealed	NULL
increases	NULL
in	NULL
phosphorylation	NULL
at	NULL
2	NULL
min	NULL
of	NULL
2.2-	NULL
,	NULL
5.3-	NULL
,	NULL
and	NULL
7.7-fold	NULL
for	NULL
proteins	NULL
292a-c	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
experiments	NULL
established	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
intensity	NULL
of	NULL
phosphoproteins	NULL
292-c	NULL
by	NULL
autoradiography	NULL
was	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
quantity	NULL
of	NULL
proteins	NULL
292a-c	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
immunoblotting	NULL
.	NULL

The	NULL
small	NULL
species	NULL
adjacent	NULL
(	NULL
acidic	NULL
)	NULL
to	NULL
29¢	NULL
was	NULL
also	NULL
demonstrable	NULL
on	NULL
both	NULL
the	NULL
immunoblot	NULL
and	NULL
the	NULL
autoradiograph	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
,	NULL
too	NULL
,	NULL
was	NULL
either	NULL
a	NULL
separate	NULL
form	NULL
of	NULL
the	NULL
27-kDa	NULL
protein	NULL
or	NULL
artifactual	NULL
and	NULL
derived	NULL
from	NULL
protein	NULL
29¢	NULL
(	NULL
cf	NULL
.	NULL

Figs	NULL
.	NULL

1-3	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
provided	NULL
strong	NULL
evidence	NULL
that	NULL
the	NULL
29-kDa	NULL
phosphoproteins	NULL
were	NULL
all	NULL
forms	NULL
of	NULL
the	NULL
same	NULL
protein	NULL
,	NULL
the	NULL
unphosphorylated	NULL
27-kDa	NULL
species	NULL
present	NULL
on	NULL
the	NULL
immunoblots	NULL
.	NULL

This	NULL
was	NULL
further	NULL
supported	NULL
by	NULL
previous	NULL
work	NULL
in	NULL
platelets	NULL
and	NULL
fibroblasts	NULL
demonstrating	NULL
identical	NULL
electropho-retic	NULL
patterns	NULL
for	NULL
these	NULL
proteins	NULL
following	NULL
limited	NULL
proteolysis	NULL
with	NULL
Staphylococcus	NULL
aureus	NULL
V8	NULL
protease	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Recognition	NULL
of	NULL
the	NULL
29-kDa	NULL
phosphoproteins	NULL
by	NULL
D5	NULL
,	NULL
a	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
an	NULL
uncharacterized	NULL
estrogen	NULL
receptor-related	NULL
29-kDa	NULL
protein	NULL
.	NULL

Two-dimensional	NULL
gels	NULL
of	NULL
*P-labeled	NULL
platelet	NULL
lysates	NULL
(	NULL
10°	NULL
platelets	NULL
per	NULL
gel	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
unstimu-lated	NULL
platelets	NULL
(	NULL
control	NULL
)	NULL
or	NULL
platelets	NULL
exposed	NULL
to	NULL
human	NULL
thrombin	NULL
for	NULL
2	NULL
min	NULL
(	NULL
thrombin	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
then	NULL
electroblotted	NULL
to	NULL
PVDF	NULL
and	NULL
probed	NULL
with	NULL
DS	NULL
,	NULL
an	NULL
antibody	NULL
raised	NULL
against	NULL
a	NULL
29-kDa	NULL
phosphoprotein	NULL
copurified	NULL
with	NULL
the	NULL
estrogen	NULL
receptor	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
immunoblots	NULL
(	NULL
Upper	NULL
)	NULL
were	NULL
developed	NULL
and	NULL
visualized	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
placed	NULL
on	NULL
film	NULL
to	NULL
generate	NULL
the	NULL
corresponding	NULL
autoradiographs	NULL
(	NULL
Lower	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
two-dimensional	NULL
immunoblots	NULL
and	NULL
autoradiographs	NULL
is	NULL
displayed	NULL
(	NULL
cf	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
phosphoprotems	NULL
29a-c	NULL
(	NULL
Lower	NULL
)	NULL
were	NULL
localized	NULL
by	NULL
pi	NULL
and	NULL
molecular	NULL
size	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
and	NULL
were	NULL
superimposable	NULL
on	NULL
the	NULL
corresponding	NULL
proteins	NULL
of	NULL
the	NULL
immunoblots	NULL
displayed	NULL
(	NULL
Upper	NULL
)	NULL
.	NULL

Along	NULL
with	NULL
proteins	NULL
29a-c	NULL
,	NULL
a	NULL
more	NULL
basic	NULL
27-kDa	NULL
protein	NULL
was	NULL
evident	NULL
on	NULL
the	NULL
immunoblots	NULL
(	NULL
arrowheads	NULL
)	NULL
.	NULL

No	NULL
other	NULL
proteins	NULL
were	NULL
detected	NULL
anywhere	NULL
on	NULL
the	NULL
two-dimensional	NULL
immunoblots	NULL
.	NULL

The	NULL
control	NULL
immunoblot	NULL
contained	NULL
a	NULL
faint	NULL
protein	NULL
corresponding	NULL
to	NULL
29¢	NULL
that	NULL
is	NULL
not	NULL
well	NULL
reproduced	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Cell	NULL
Biology	NULL
:	NULL
Mendelsohn	NULL
et	NULL
al	NULL
.	NULL

the	NULL
protein	NULL
recognized	NULL
by	NULL
the	NULL
D5	NULL
antibody	NULL
to	NULL
the	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
was	NULL
determined	NULL
next	NULL
using	NULL
molecular	NULL
cloning	NULL
techniques	NULL
.	NULL

Screening	NULL
of	NULL
Human	NULL
Agt11	NULL
Expression	NULL
Libraries	NULL
with	NULL
Monoclonal	NULL
Antibody	NULL
DS	NULL
,	NULL
Isolation	NULL
of	NULL
cDNA	NULL
,	NULL
and	NULL
Identification	NULL
of	NULL
the	NULL
Clone	NULL
Recognized	NULL
as	NULL
Expressing	NULL
the	NULL
27-kDa	NULL
Heat	NULL
Shock	NULL
Protein	NULL
.	NULL

Human	NULL
Agt11	NULL
cDNA	NULL
expression	NULL
libraries	NULL
from	NULL
platelets	NULL
(	NULL
25	NULL
)	NULL
and	NULL
endothelial	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
were	NULL
screened	NULL
.	NULL

Screening	NULL
of	NULL
~=150,000	NULL
plaques	NULL
each	NULL
from	NULL
a	NULL
human	NULL
platelet	NULL
cDNA	NULL
library	NULL
and	NULL
an	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
-primed	NULL
endothelial	NULL
cell	NULL
library	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
single	NULL
plaque	NULL
from	NULL
the	NULL
endothelial	NULL
library	NULL
recognized	NULL
by	NULL
the	NULL
DS	NULL
antibody	NULL
.	NULL

The	NULL
recombinant	NULL
was	NULL
plaque-purified	NULL
and	NULL
its	NULL
DNA	NULL
insert	NULL
was	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
for	NULL
amplification	NULL
and	NULL
sequencing	NULL
.	NULL

Three	NULL
hundred	NULL
forty-eight	NULL
bases	NULL
were	NULL
sequenced	NULL
and	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
was	NULL
used	NULL
to	NULL
search	NULL
the	NULL
Protein	NULL
Identification	NULL
Resource	NULL
data	NULL
base	NULL
(	NULL
National	NULL
Biomedical	NULL
Research	NULL
Foundation	NULL
;	NULL
May	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
clone	NULL
identified	NULL
by	NULL
the	NULL
DS	NULL
antibody	NULL
was	NULL
identical	NULL
to	NULL
the	NULL
mammalian	NULL
27-kDa	NULL
heat	NULL
shock	NULL
protein	NULL
,	NULL
HSP27	NULL
(	NULL
34	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
these	NULL
findings	NULL
,	NULL
the	NULL
DS	NULL
antibody	NULL
was	NULL
used	NULL
in	NULL
immunoprecipitation	NULL
experiments	NULL
with	NULL
resting	NULL
and	NULL
thrombin-stimulated	NULL
platelets	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

First	NULL
,	NULL
immunoprecipitation	NULL
studies	NULL
using	NULL
*P-labeled	NULL
platelets	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
D5	NULL
antibody	NULL
to	NULL
demonstrate	NULL
the	NULL
resting	NULL
phosphorylation	NULL
and	NULL
predicted	NULL
increase	NULL
in	NULL
phosphorylated	NULL
forms	NULL
of	NULL
HSP27	NULL
following	NULL
thrombin	NULL
stimulation	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
resolved	NULL
by	NULL
SDS/12.5	NULL
%	NULL
PAGE	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

A	NULL
3.2-fold	NULL
increase	NULL
in	NULL
total	NULL
29-kDa	NULL
protein	NULL
phosphorylation	NULL
was	NULL
observed	NULL
2	NULL
min	NULL
after	NULL
stimulation	NULL
with	NULL
thrombin	NULL
at	NULL
1	NULL
unit/ml	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Leff	NULL
)	NULL
.	NULL

No	NULL
other	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
.	NULL

In	NULL
preliminary	NULL
immunoprecipitation	NULL
studies	NULL
of	NULL
the	NULL
time	NULL
course	NULL
of	NULL
phosphorylation	NULL
,	NULL
we	NULL
found	NULL
near-complete	NULL
phosphorylation	NULL
of	NULL
the	NULL
29-kDa	NULL
proteins	NULL
within	NULL
10	NULL
sec	NULL
following	NULL
thrombin	NULL
stimulation	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
these	NULL
phosphorylation	NULL
events	NULL
in	NULL
platelet	NULL
signal	NULL
transduction	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
10	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
will	NULL
be	NULL
necessary	NULL
,	NULL
however	NULL
,	NULL
to	NULL
quantitate	NULL
precisely	NULL
the	NULL
time	NULL
course	NULL
for	NULL
total	NULL
29-kDa	NULL
phosphorylation	NULL
and	NULL
the	NULL
individual	NULL
time	NULL
courses	NULL
of	NULL
phosphorylation	NULL
for	NULL
292-c	NULL
and	NULL
to	NULL
correlate	NULL
these	NULL
with	NULL
specific	NULL
platelet	NULL
activation	NULL
events	NULL
.	NULL

Next	NULL
,	NULL
a	NULL
separate	NULL
anti-HSP27	NULL
monoclonal	NULL
antibody	NULL
was	NULL
used	NULL
to	NULL
probe	NULL
immunoblots	NULL
prepared	NULL
from	NULL
DS	NULL
immunoprecipitates	NULL
of	NULL
unlabeled	NULL
platelets	NULL
at	NULL
rest	NULL
or	NULL
following	NULL
thrombin	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Right	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
resolved	NULL
in	NULL
12.5	NULL
%	NULL
gels	NULL
,	NULL
with	NULL
2-mercaptoethanol	NULL
omitted	NULL
from	NULL
the	NULL
sample	NULL
buffer	NULL
to	NULL
prevent	NULL
reduction	NULL
of	NULL
the	NULL
D5	NULL
antibody	NULL
.	NULL

This	NULL
omission	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
migration	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
27-	NULL
to	NULL
29-kDa	NULL
proteins	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
immunoprecipitated	NULL
by	NULL
the	NULL
DS	NULL
antibody	NULL
to	NULL
the	NULL
1	NULL
21	NULL
41	NULL
GECAAGCACGAGCAGCGGCAGGACGAGCATGGCTACATCTCCCGGTGCTTCACGCGGAAA	NULL
GlyLysHisGluGluArgGlnAspGluHisGlyTyrIleSerArgCysPheThrAngys	NULL
61	NULL
81	NULL
101	NULL
TACACGCTGCCCCCCGGTGTGGACCCCACCCAAGTTTCCTCCTCCCTeTCccecTcaceec	NULL
TerhrLeuPronoGlyvalAspProThrGanalSerSerSerLeUSerProGluGly	NULL
121	NULL
141	NULL
161	NULL
ACACTGACCGTEGAGGCCCCCATGCCCAAGCTAGCCACGCAGTCCAACGAGATCACCATC	NULL
ThrLeuThrValGluAlaProMetProlLysLeuAlaThrGlnSerAsnGluileThrIle	NULL
181	NULL
201	NULL
221	NULL
CCAGTCACCTTCGAGTCGCGGGCCCAGCTTGGGGGCAGAAGCTGCAAAATCCGATGAGAC	NULL
ProValThrPheGluSerArgAlaGlnLeuGlyGlyArgSerCysLysIleArg***	NULL
241	NULL
261	NULL
281	NULL
TGCCGCCAAGTAAAGCCTTAGCCCGGATGCCCACCCCTGCTGCCGCCACTGGCTGTGCCT	NULL
301	NULL
cecececcaceTGTeTeTTCcTrTTcaATACATTTATCTTCTGTTTTTCTC	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

-	NULL
Nucleotide	NULL
and	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
clone	NULL
recognized	NULL
by	NULL
the	NULL
DS	NULL
antibody	NULL
.	NULL

The	NULL
348	NULL
base	NULL
pairs	NULL
correspond	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
HSP27	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
deduced	NULL
78-amino	NULL
acid	NULL
sequence	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
carboxyl	NULL
terminus	NULL
of	NULL
mammalian	NULL
HSP27	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
-	NULL
11215	NULL
31	NULL
34	NULL
«	NULL
ro	NULL
Git	NULL
$	NULL
.	NULL

s	NULL
HSP27	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Proteins	NULL
immunoprecipitated	NULL
from	NULL
human	NULL
platelets	NULL
by	NULL
the	NULL
DS	NULL
antibody	NULL
to	NULL
the	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
are	NULL
phosphorylated	NULL
and	NULL
are	NULL
recognized	NULL
by	NULL
a	NULL
distinct	NULL
monoclonal	NULL
antibody	NULL
to	NULL
HSP27	NULL
.	NULL

(	NULL
Left	NULL
)	NULL
Platelet	NULL
immunoprecipitates	NULL
were	NULL
prepared	NULL
from	NULL
P-labeled	NULL
control	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
and	NULL
thrombin-activated	NULL
(	NULL
lane	NULL
T	NULL
)	NULL
platelets	NULL
with	NULL
the	NULL
DS	NULL
antibody	NULL
and	NULL
subjected	NULL
to	NULL
SDS/PAGE	NULL
followed	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
Right	NULL
)	NULL
In	NULL
separate	NULL
experiments	NULL
,	NULL
platelet	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
using	NULL
DS	NULL
antibody	NULL
,	NULL
subjected	NULL
to	NULL
SDS/	NULL
PAGE	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
a	NULL
distinct	NULL
murine	NULL
monoclonal	NULL
antibody	NULL
to	NULL
HSP27	NULL
.	NULL

The	NULL
proteins	NULL
recognized	NULL
by	NULL
the	NULL
anti-HSP27	NULL
antibody	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
portion	NULL
of	NULL
each	NULL
gel	NULL
between	NULL
22	NULL
and	NULL
35	NULL
kDa	NULL
is	NULL
shown	NULL
.	NULL

estrogen	NULL
receptor-related	NULL
protein	NULL
were	NULL
precisely	NULL
recognized	NULL
by	NULL
a	NULL
distinct	NULL
monoclonal	NULL
antibody	NULL
to	NULL
mammalian	NULL
HSP27	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
Right	NULL
)	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
D5	NULL
antibody	NULL
itself	NULL
,	NULL
no	NULL
other	NULL
proteins	NULL
were	NULL
recognized	NULL
on	NULL
these	NULL
immunoblots	NULL
.	NULL

DISCUSSION	NULL
Platelet	NULL
activation	NULL
in	NULL
hemostasis	NULL
and	NULL
thrombosis	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
number	NULL
of	NULL
protein	NULL
phosphorylation	NULL
events	NULL
that	NULL
are	NULL
presumed	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
morphologic	NULL
and	NULL
secretory	NULL
events	NULL
that	NULL
ensue	NULL
.	NULL

The	NULL
present	NULL
study	NULL
characterizes	NULL
the	NULL
rapid	NULL
incorporation	NULL
of	NULL
*P	NULL
into	NULL
three	NULL
29-kDa	NULL
platelet	NULL
proteins	NULL
following	NULL
cell	NULL
activation	NULL
by	NULL
thrombin	NULL
.	NULL

The	NULL
observed	NULL
time	NULL
course	NULL
of	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
29a-c	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
time	NULL
course	NULL
of	NULL
platelet	NULL
activation	NULL
by	NULL
thrombin	NULL
and	NULL
other	NULL
agonists	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
10	NULL
,	NULL
29	NULL
)	NULL
,	NULL
lending	NULL
support	NULL
to	NULL
the	NULL
potential	NULL
relevance	NULL
of	NULL
these	NULL
phosphorylation	NULL
events	NULL
in	NULL
platelet	NULL
signal	NULL
transduction	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
identify	NULL
proteins	NULL
29a-c	NULL
as	NULL
forms	NULL
of	NULL
HSP27	NULL
,	NULL
a	NULL
low	NULL
molecular	NULL
weight	NULL
member	NULL
of	NULL
the	NULL
heat	NULL
shock	NULL
protein	NULL
family	NULL
.	NULL

The	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
are	NULL
ubiquitous	NULL
and	NULL
are	NULL
more	NULL
diverse	NULL
than	NULL
the	NULL
larger	NULL
heat	NULL
shock	NULL
proteins	NULL
,	NULL
differing	NULL
in	NULL
number	NULL
between	NULL
organisms	NULL
and	NULL
divergent	NULL
in	NULL
sequence	NULL
from	NULL
one	NULL
organism	NULL
to	NULL
another	NULL
(	NULL
13	NULL
)	NULL
.	NULL

All	NULL
share	NULL
carboxyl-terminal	NULL
homology	NULL
with	NULL
the	NULL
lens	NULL
structural	NULL
protein	NULL
a-crystallin	NULL
and	NULL
are	NULL
able	NULL
to	NULL
form	NULL
large	NULL
intracellular	NULL
polymeric	NULL
aggregates	NULL
,	NULL
perhaps	NULL
through	NULL
interactions	NULL
involving	NULL
this	NULL
region	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
demonstrated	NULL
that	NULL
a	NULL
B-crystallin	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
protein	NULL
family	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
subcellular	NULL
distribution	NULL
of	NULL
the	NULL
small	NULL
heat	NULL
shock	NULL
proteins	NULL
varies	NULL
,	NULL
depending	NULL
on	NULL
cell	NULL
type	NULL
and	NULL
perhaps	NULL
as	NULL
well	NULL
on	NULL
different	NULL
degrees	NULL
of	NULL
phosphorylation	NULL
(	NULL
13	NULL
,	NULL
36-38	NULL
)	NULL
,	NULL
though	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
different	NULL
cellular	NULL
dispositions	NULL
of	NULL
the	NULL
proteins	NULL
remains	NULL
unclear	NULL
.	NULL

HSP27	NULL
is	NULL
known	NULL
to	NULL
be	NULL
phosphorylated	NULL
to	NULL
several	NULL
forms	NULL
during	NULL
normal	NULL
cellular	NULL
events	NULL
,	NULL
depending	NULL
on	NULL
stimulus	NULL
and	NULL
cell	NULL
type	NULL
(	NULL
13	NULL
,	NULL
36	NULL
,	NULL
39-43	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
,	NULL
and	NULL
the	NULL
recognition	NULL
of	NULL
three	NULL
distinct	NULL
phosphorylated	NULL
forms	NULL
of	NULL
HSP27	NULL
in	NULL
human	NULL
platelets	NULL
,	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
may	NULL
regulate	NULL
HSP27	NULL
function	NULL
.	NULL

In	NULL
mammalian	NULL
cells	NULL
,	NULL
varying	NULL
degrees	NULL
of	NULL
HSP27	NULL
phosphorylation	NULL
have	NULL
been	NULL
shown	NULL
following	NULL
stimulation	NULL
by	NULL
phorbol	NULL
esters	NULL
,	NULL
calcium	NULL
ionophore	NULL
,	NULL
or	NULL
serum	NULL
(	NULL
36	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
by	NULL
the	NULL
mitogens	NULL
interleukin	NULL
1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
previous	NULL
pharmacologic	NULL
attempts	NULL
to	NULL
explore	NULL
HSP27	NULL
phosphorylation	NULL
(	NULL
12	NULL
,	NULL
33	NULL
,	NULL
36	NULL
,	NULL
40	NULL
,	NULL
42	NULL
)	NULL
,	NULL
and	NULL
the	NULL
recent	NULL
identification	NULL
of	NULL
two	NULL
phosphorylation	NULL
sites	NULL
in	NULL
the	NULL
murine	NULL
small	NULL
heat	NULL
shock	NULL
protein	NULL
(	NULL
44	NULL
)	NULL
,	NULL
the	NULL
specific	NULL
protein	NULL
kinases	NULL
involved	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
HSP27	NULL
remain	NULL
unidentified	NULL
.	NULL

The	NULL
identity	NULL
between	NULL
HSP27	NULL
and	NULL
the	NULL
estrogen	NULL
receptor-related	NULL
29-kDa	NULL
protein	NULL
P29	NULL
is	NULL
also	NULL
noteworthy	NULL
.	NULL

Coffer	NULL
and	NULL
colleagues	NULL
(	NULL
16	NULL
,	NULL
30	NULL
)	NULL
first	NULL
found	NULL
P29	NULL
while	NULL
preparing	NULL
antibodies	NULL
against	NULL
the	NULL
estrogen	NULL
receptor	NULL
.	NULL

Although	NULL
identification	NULL
of	NULL
P29	NULL
11216	NULL
-	NULL
Cell	NULL
Biology	NULL
:	NULL
Mendelsohn	NULL
et	NULL
al	NULL
.	NULL

remained	NULL
elusive	NULL
(	NULL
45	NULL
)	NULL
,	NULL
characteristics	NULL
of	NULL
the	NULL
protein	NULL
suggested	NULL
to	NULL
those	NULL
investigators	NULL
the	NULL
application	NULL
of	NULL
P29	NULL
as	NULL
a	NULL
marker	NULL
for	NULL
estrogen	NULL
responsiveness	NULL
in	NULL
tumor	NULL
tissues	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Working	NULL
separately	NULL
,	NULL
McGuire	NULL
and	NULL
colleagues	NULL
(	NULL
47-49	NULL
)	NULL
had	NULL
earlier	NULL
identified	NULL
a	NULL
``	NULL
©24-kDa	NULL
``	NULL
'	NULL
protein	NULL
as	NULL
such	NULL
a	NULL
marker	NULL
in	NULL
breast	NULL
cancer	NULL
,	NULL
then	NULL
demonstrated	NULL
the	NULL
24-kDa	NULL
protein	NULL
to	NULL
be	NULL
transcriptionally	NULL
induced	NULL
by	NULL
estrogen	NULL
,	NULL
and	NULL
more	NULL
recently	NULL
have	NULL
shown	NULL
this	NULL
protein	NULL
to	NULL
be	NULL
HSP27	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
estrogen	NULL
receptor-related	NULL
protein	NULL
as	NULL
HSP27	NULL
strongly	NULL
suggests	NULL
that	NULL
HSP27	NULL
is	NULL
both	NULL
transcriptionally	NULL
induced	NULL
by	NULL
estrogen	NULL
and	NULL
interacts	NULL
with	NULL
the	NULL
estrogen	NULL
receptor	NULL
,	NULL
though	NULL
the	NULL
latter	NULL
remains	NULL
to	NULL
be	NULL
established	NULL
.	NULL

If	NULL
so	NULL
,	NULL
this	NULL
defines	NULL
a	NULL
potentially	NULL
important	NULL
regulatory	NULL
loop	NULL
in	NULL
estrogen-responsive	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
also	NULL
allow	NULL
speculation	NULL
regarding	NULL
possible	NULL
links	NULL
between	NULL
estrogen	NULL
responsiveness	NULL
and	NULL
the	NULL
cells	NULL
that	NULL
participate	NULL
in	NULL
hemostasis	NULL
and	NULL
thrombosis	NULL
.	NULL

The	NULL
specific	NULL
role	NULL
of	NULL
HSP27	NULL
and	NULL
its	NULL
phosphorylation	NULL
in	NULL
platelet	NULL
activation	NULL
events	NULL
is	NULL
entirely	NULL
unknown	NULL
.	NULL

Platelets	NULL
do	NULL
not	NULL
have	NULL
nuclei	NULL
,	NULL
display	NULL
little	NULL
protein	NULL
synthetic	NULL
function	NULL
(	NULL
50	NULL
)	NULL
,	NULL
and	NULL
have	NULL
yet	NULL
to	NULL
be	NULL
demonstrated	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
estrogen	NULL
or	NULL
other	NULL
steroid	NULL
hormones	NULL
.	NULL

Some	NULL
possible	NULL
roles	NULL
for	NULL
HSP27	NULL
in	NULL
platelet	NULL
activation	NULL
include	NULL
a	NULL
chaperone	NULL
function	NULL
for	NULL
an	NULL
unidentified	NULL
steroid	NULL
receptor	NULL
or	NULL
other	NULL
protein	NULL
(	NULL
14	NULL
)	NULL
,	NULL
interaction	NULL
in	NULL
a	NULL
protooncogenic	NULL
signal	NULL
transduction	NULL
pathway	NULL
(	NULL
11	NULL
,	NULL
13	NULL
,	NULL
51	NULL
)	NULL
,	NULL
participation	NULL
in	NULL
non-nuclear	NULL
,	NULL
steroid-mediated	NULL
events	NULL
(	NULL
52	NULL
)	NULL
,	NULL
or	NULL
direct	NULL
participation	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
HSP27	NULL
forms	NULL
in	NULL
the	NULL
cytoskeletal	NULL
,	NULL
membrane	NULL
,	NULL
or	NULL
secretory	NULL
reorganizational	NULL
events	NULL
that	NULL
occur	NULL
with	NULL
cell	NULL
activation	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
George	NULL
Perides	NULL
for	NULL
technical	NULL
suggestions	NULL
and	NULL
advice	NULL
and	NULL
to	NULL
Myles	NULL
Brown	NULL
,	NULL
Michael	NULL
Charness	NULL
,	NULL
and	NULL
Mitchell	NULL
Lazar	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
frequent	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
the	NULL
WRV	NULL
A	NULL
Medical	NULL
Media	NULL
department	NULL
and	NULL
Ms.	NULL
Stephanie	NULL
Tribuna	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Award	NULL
HLO2154	NULL
and	NULL
by	NULL
a	NULL
Merit	NULL
Review	NULL
Award	NULL
from	NULL
the	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Research	NULL
Service	NULL
.	NULL

1	NULL
.	NULL

Berndt	NULL
,	NULL
M.	NULL
C.	NULL
&	NULL
Phillips	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1981	NULL
)	NULL
in	NULL
Platelets	NULL
in	NULL
Biology	NULL
and	NULL
Pathology	NULL
,	NULL
ed	NULL
.	NULL

Gordon	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
Elsevier/North	NULL
Holland	NULL
Biomedical	NULL
,	NULL
Amsterdam	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

43-74	NULL
.	NULL

2	NULL
.	NULL

Huang	NULL
,	NULL
E.	NULL
M.	NULL
&	NULL
Detwiler	NULL
,	NULL
T.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
in	NULL
Biochemistry	NULL
of	NULL
Platelets	NULL
,	NULL
eds	NULL
.	NULL

Phillips	NULL
,	NULL
D.	NULL
R.	NULL
&	NULL
Shuman	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
Academic	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

1-12	NULL
.	NULL

3	NULL
.	NULL

Eidt	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Allison	NULL
,	NULL
P.	NULL
,	NULL
Nobel	NULL
,	NULL
S.	NULL
,	NULL
Ashton	NULL
,	NULL
J.	NULL
,	NULL
Golino	NULL
,	NULL
P.	NULL
,	NULL
McNatt	NULL
,	NULL
J.	NULL
,	NULL
Buja	NULL
,	NULL
L.	NULL
M.	NULL
&	NULL
Willerson	NULL
,	NULL
J.	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84	NULL
,	NULL
18-27	NULL
.	NULL

4	NULL
.	NULL

Kroll	NULL
,	NULL
M.	NULL
H.	NULL
&	NULL
Schafer	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
4	NULL
,	NULL
1181-1195	NULL
.	NULL

5	NULL
.	NULL

Vu	NULL
,	NULL
T.-K.	NULL
H.	NULL
,	NULL
Hung	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
Wheaton	NULL
,	NULL
V.	NULL
I	NULL
.	NULL

&	NULL
Coughlin	NULL
,	NULL
S.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
1057-1068	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Hunter	NULL
,	NULL
T.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
50	NULL
,	NULL
823-829	NULL
.	NULL

7	NULL
.	NULL

Blackshear	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Nairn	NULL
,	NULL
A.	NULL
C.	NULL
&	NULL
Kuo	NULL
,	NULL
J.	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

2	NULL
,	NULL
2957-2969	NULL
.	NULL

8	NULL
.	NULL

Ferrell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Martin	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20723-20729	NULL
.	NULL

9	NULL
.	NULL

Lyons	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Stanford	NULL
,	NULL
N.	NULL
&	NULL
Majerus	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1975	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

56	NULL
,	NULL
924-936	NULL
.	NULL

10	NULL
.	NULL

Haslam	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Salama	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Fox	NULL
,	NULL
J.	NULL
E.	NULL
B.	NULL
,	NULL
Lynham	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Davidson	NULL
,	NULL
M.	NULL
M.	NULL
L.	NULL
(	NULL
1980	NULL
)	NULL
in	NULL
Platelets	NULL
:	NULL
Cellular	NULL
Response	NULL
Mechanisms	NULL
and	NULL
Their	NULL
Biological	NULL
Significance	NULL
,	NULL
eds	NULL
.	NULL

Rotman	NULL
,	NULL
A.	NULL
,	NULL
Meyer	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Gitler	NULL
,	NULL
C.	NULL
&	NULL
Silberberg	NULL
,	NULL
A	NULL
.	NULL

(	NULL
Wiley	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

213-231	NULL
.	NULL

11	NULL
.	NULL

Chambard	NULL
,	NULL
J.-C.	NULL
&	NULL
Pouyssegur	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

3	NULL
,	NULL
1034-1044	NULL
.	NULL

12	NULL
.	NULL

Demolle	NULL
,	NULL
D.	NULL
,	NULL
Lecomte	NULL
,	NULL
M.	NULL
&	NULL
Boeynaems	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
18459-18465	NULL
.	NULL

13	NULL
.	NULL

Lindquist	NULL
,	NULL
S.	NULL
&	NULL
Craig	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Genet	NULL
.	NULL

22	NULL
,	NULL
631-677	NULL
.	NULL

14	NULL
.	NULL

-	NULL
Schlesinger	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
12111-12114	NULL
.	NULL

15	NULL
.	NULL

Pratt	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

74	NULL
,	NULL
C69-C76	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
(	NULL
1991	NULL
)	NULL
Coffer	NULL
,	NULL
A.	NULL
I.	NULL
,	NULL
Lewis	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Brockas	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

&	NULL
King	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

45	NULL
,	NULL
3686-3693	NULL
.	NULL

Mendelsohn	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
O'Neill	NULL
,	NULL
S.	NULL
,	NULL
George	NULL
,	NULL
D.	NULL
&	NULL
Loscalzo	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
19028-19034	NULL
.	NULL

Kroll	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Zavoico	NULL
,	NULL
G.	NULL
B	NULL
.	NULL

&	NULL
Schafer	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
970	NULL
,	NULL
61-67	NULL
.	NULL

Celis	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Two	NULL
Dimensional	NULL
Electrophoresis	NULL
of	NULL
Proteins	NULL
:	NULL
Methods	NULL
and	NULL
Applications	NULL
(	NULL
Academic	NULL
,	NULL
Or-lando	NULL
,	NULL
FL	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

3-36	NULL
.	NULL

Morissey	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1981	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

117	NULL
,	NULL
307-310	NULL
.	NULL

Towbin	NULL
,	NULL
H.	NULL
,	NULL
Staehlin	NULL
,	NULL
T.	NULL
&	NULL
Gordon	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
76	NULL
,	NULL
4350-4354	NULL
.	NULL

Billingsley	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Pennypacker	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Hoover	NULL
,	NULL
G.C	NULL
.	NULL

&	NULL
Kincaid	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Biotechniques	NULL
5	NULL
,	NULL
22-31	NULL
.	NULL

Mitchell	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Jefferson	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
Bejeck	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Brugge	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Deuel	NULL
,	NULL
T.	NULL
F.	NULL
&	NULL
Majerus	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9396-9400	NULL
.	NULL

Ginsburg	NULL
,	NULL
D.	NULL
,	NULL
Zeheb	NULL
,	NULL
R.	NULL
,	NULL
Yang	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Rafferty	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
An-dreasen	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Nielsen	NULL
,	NULL
L.	NULL
,	NULL
Dano	NULL
,	NULL
K.	NULL
,	NULL
Lebo	NULL
,	NULL
R.	NULL
V.	NULL
&	NULL
Ge-lehrter	NULL
,	NULL
T.	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

78	NULL
,	NULL
1673-1680	NULL
.	NULL

Wicki	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Walz	NULL
,	NULL
A.	NULL
,	NULL
Gerger-Huber	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
Wenger	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Vornhagen	NULL
,	NULL
R.	NULL
&	NULL
Clemetson	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Thromb	NULL
.	NULL

Haemosta-sis	NULL
61	NULL
,	NULL
448-453	NULL
.	NULL

Mierendorf	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Percy	NULL
,	NULL
C.	NULL
&	NULL
Young	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

152	NULL
,	NULL
458-469	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
2nd	NULL
Ed	NULL
.	NULL

Sanger	NULL
,	NULL
F.	NULL
,	NULL
Nickien	NULL
,	NULL
S.	NULL
&	NULL
Coulson	NULL
,	NULL
A.	NULL
R.	NULL
(	NULL
1977	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
74	NULL
,	NULL
5463-5467	NULL
.	NULL

Ferrell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Martin	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
3603-3610	NULL
.	NULL

King	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Finley	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Coffer	NULL
,	NULL
A.	NULL
I.	NULL
,	NULL
Millis	NULL
,	NULL
R.	NULL
R.	NULL
&	NULL
Rubens	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

27	NULL
,	NULL
471-475	NULL
.	NULL

Coffer	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

&	NULL
King	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

31	NULL
,	NULL
745-750	NULL
.	NULL

Darbon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Issandou	NULL
,	NULL
M.	NULL
,	NULL
Tournier	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Bayard	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

168	NULL
,	NULL
527-536	NULL
.	NULL

Levin	NULL
,	NULL
E.	NULL
G.	NULL
&	NULL
Santell	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
174-181	NULL
.	NULL

Hickey	NULL
,	NULL
E.	NULL
,	NULL
Brandon	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Potter	NULL
,	NULL
R.	NULL
,	NULL
Stein	NULL
,	NULL
G.	NULL
,	NULL
Stein	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Weber	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14	NULL
,	NULL
4127-4145	NULL
.	NULL

Klemenz	NULL
,	NULL
R.	NULL
,	NULL
Frohli	NULL
,	NULL
E.	NULL
,	NULL
Steiger	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Schafer	NULL
,	NULL
R.	NULL
&	NULL
Aoyama	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88	NULL
,	NULL
3652-3656	NULL
.	NULL

Welch	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260	NULL
,	NULL
3058-3062	NULL
.	NULL

Arrigo	NULL
,	NULL
A.-P.	NULL
,	NULL
Suhan	NULL
,	NULL
J.	NULL
P.	NULL
&	NULL
Welch	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
5059-5071	NULL
.	NULL

Arrigo	NULL
,	NULL
A.-P.	NULL
&	NULL
Welch	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
15359-15369	NULL
.	NULL

Kim	NULL
,	NULL
Y.-J	NULL
.	NULL

,	NULL
Shuman	NULL
,	NULL
J.	NULL
,	NULL
Sette	NULL
,	NULL
M.	NULL
&	NULL
Przybyla	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

117	NULL
,	NULL
682-687	NULL
.	NULL

Regazzi	NULL
,	NULL
R.	NULL
,	NULL
Eppenberger	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Fabbrjo	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

152	NULL
,	NULL
62068	NULL
.	NULL

Kaur	NULL
,	NULL
P.	NULL
,	NULL
Welch	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

&	NULL
Saklatvala	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

258	NULL
,	NULL
269-273	NULL
.	NULL

Arrigo	NULL
,	NULL
A.-P.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1276-1280	NULL
.	NULL

Crete	NULL
,	NULL
P.	NULL
&	NULL
Landry	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Radiat	NULL
.	NULL

Res	NULL
.	NULL

121	NULL
,	NULL
320-327	NULL
.	NULL

Gaestel	NULL
,	NULL
M.	NULL
,	NULL
Schroder	NULL
,	NULL
W.	NULL
,	NULL
Benndorf	NULL
,	NULL
R.	NULL
,	NULL
Lippmann	NULL
,	NULL
C.	NULL
,	NULL
Buchner	NULL
,	NULL
K.	NULL
,	NULL
Hucho	NULL
,	NULL
F.	NULL
,	NULL
Erdmann	NULL
,	NULL
V.	NULL
A	NULL
.	NULL

&	NULL
Bielka	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
14721-14724	NULL
.	NULL

Hayward	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Coffer	NULL
,	NULL
A.	NULL
I	NULL
.	NULL

&	NULL
King	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

37	NULL
,	NULL
513-519	NULL
.	NULL

Coffer	NULL
,	NULL
A.	NULL
I.	NULL
,	NULL
Glover	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Millis	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Rubens	NULL
,	NULL
R.	NULL
D.	NULL
&	NULL
King	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Prog	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

Ther	NULL
.	NULL

35	NULL
,	NULL
294-299	NULL
.	NULL

Edwards	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Adams	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

&	NULL
McGuire	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1981	NULL
)	NULL
Breast	NULL
Cancer	NULL
Res	NULL
.	NULL

Treat	NULL
.	NULL

1	NULL
,	NULL
209-233	NULL
.	NULL

Adams	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Hajj	NULL
,	NULL
H.	NULL
,	NULL
Edwards	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Bjercke	NULL
,	NULL
R.J.	NULL
&	NULL
McGuire	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1983	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

43	NULL
,	NULL
4297-4301	NULL
.	NULL

Fuqua	NULL
,	NULL
S.	NULL
A.	NULL
W.	NULL
,	NULL
Blum-Salingaros	NULL
,	NULL
M.	NULL
&	NULL
McGuire	NULL
,	NULL
W.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

49	NULL
,	NULL
4126-4129	NULL
.	NULL

Ludany	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Kellermayer	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Clin	NULL
.	NULL

Biochem	NULL
.	NULL

21	NULL
,	NULL
107-110	NULL
.	NULL

Cantley	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Auger	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Carpenter	NULL
,	NULL
C.	NULL
,	NULL
Duckworth	NULL
,	NULL
B.	NULL
,	NULL
Graziani	NULL
,	NULL
A.	NULL
,	NULL
Kapelier	NULL
,	NULL
R.	NULL
&	NULL
Soltoff	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
281-302	NULL
.	NULL

Thomas	NULL
,	NULL
P.	NULL
&	NULL
Meizel	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

264	NULL
,	NULL
539	NULL
.	NULL

